BREAKING NEWS: IL PAPER CHE INCOLPAVA LA RANITIDINA COME POTENZIALMENTE CARCINOGENA E’ STATO RITIRATO !

Widely Covered Paper on Ranitidine-Cancer Link Retracted Retraction Watch Staff A paper linking the use of a wildly popular drug for heartburn to cancer has been retracted after the authors concluded that their widely touted finding appears to have resulted from a hiccup in the way they conducted their testing. The 2016 article, in Carcinogenesis, has…

IL MICROBIOTA UMANO E’ CAUSA DI GRAVI DISEGUAGLIANZE SOCIALI: UNA RIFLESSIONE SU PNAS

The human gut microbiome and health inequities Katherine R. Amatoa et al. Individuals who are minoritized as a result of race, sexual identity, gender, or socioeconomic status experience a higher prevalence of many diseases. Understanding the biological processes that cause and maintain these socially driven health inequities is essential for addressing them. The gut microbiome…

UN NUOVO TEST EMATICO DA SEGUIRE PER LA DIAGNOSI PRECOCE DEL CANCRO DEL COLON: CIRCULATING TUMOR DNA (ctDNA)

Simple Blood Test to Detect Colorectal Cancer Roxanne Nelson, RN, BSN In the future, a simple blood test could be added to the options for colorectal screening and could appeal to the people currently put off by the unpleasant necessities such as collecting a fecal sample, or the bowel prep before an invasive colonoscopy. The…

TOFACITINIB FUNZIONA: RIDUZIONE DECESSI DA POLMONITE PER COVID-19 DEL 37 %

Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia Patrícia O. Guimarães et al. BACKGROUND The efficacy and safety of tofacitinib, a Janus kinase inhibitor, in patients who are hospitalized with coronavirus disease 2019 (Covid-19) pneumonia are unclear. METHODS We randomly assigned, in a 1:1 ratio, hospitalized adults with Covid-19 pneumonia to receive either tofacitinib at a…

I PRIMI 100 GIORNI DEL COVID-19: LA EBM RISCHIA LA “DEBACLE”

Recruitment and Results Reporting of COVID-19 Randomized Clinical Trials Registered in the First 100 Days of the Pandemic Perrine Janiaud, et al Overall, 30% of COVID-19 RCTs initiated in the first 100 days of the pandemic did not begin recruitment, and only 10% had results reported by mid-October, suggesting the possibility of substantial research waste…

STENTING DELL’ESOFAGO: ULTIME LINEE GUIDA ESGE 2021

Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021 Manon C. W. Spaander et al. Main recommendations Malignant disease 1 ESGE recommends placement of partially or fully covered self-expandable metal stents (SEMSs) for palliation of malignant dysphagia over laser therapy, photodynamic therapy, and esophageal bypass. Strong recommendation, high…